Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 283

The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.

Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention

Open access
Xiong, Ailian, Yang, Zhengduo, Shen, Yicheng, Zhou, Jia, Shen, Qiang·2014·Cancers

Abstract

Signal Transducers and Activators of Transcription (STATs) are a family of transcription factors that regulate cell proliferation, differentiation, apoptosis, immune and inflammatory responses, and angiogenesis. Cumulative evidence has established that STAT3 has a critical role in the development of multiple cancer types. Because it is constitutively activated during disease progression and metastasis in a variety of cancers, STAT3 has promise as a drug target for cancer therapeutics. Recently, STAT3 was found to have an important role in maintaining cancer stem cells in vitro and in mouse tumor models, suggesting STAT3 is integrally involved in tumor initiation, progression and maintenance. STAT3 has been traditionally considered as nontargetable or undruggable, and the lag in developing effective STAT3 inhibitors contributes to the current lack of FDA-approved STAT3 inhibitors. Recent advances in cancer biology and drug discovery efforts have shed light on targeting STAT3 globally and/or specifically for cancer therapy. In this review, we summarize current literature and discuss the potential importance of STAT3 as a novel target for cancer prevention and of STAT3 inhibitors as effective chemopreventive agents.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers6020926

Cites

198 of 198 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 198 references

Research works printed but not linked: 7

  1. Dimberg, 2012, Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma, BMC Cancer, 12, 318, 10.1186/1471-2407-12-318 · doi:10.1186/1471-2407-12-318
  2. Gronowski, 1995, In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3, Mol. Endocrinol., 9, 171
  3. Wang, 2012, STAT3 mediates resistance of CD44(+)CD24(−/low) breast cancer stem cells to tamoxifen in vitro, J. Biomed. Res., 26, 325, 10.7555/JBR.26.20110050 · doi:10.7555/jbr.26.20110050
  4. Shore, 1994, Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells, Oncogene, 9, 2425
  5. Liang, 2011, Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo, Asian J. Androl., 13, 481, 10.1038/aja.2010.167 · doi:10.1038/aja.2010.167
  6. Oyaizu, 2012, Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury, Intensive Care Med., 38, 894, 10.1007/s00134-012-2498-z · doi:10.1007/s00134-012-2498-z
  7. Jung, 2013, Apoptosis induced by tanshinone IIA and cryptotanshinone is mediated by distinct JAK/STAT3/5 and SHP1/2 signaling in chronic myeloid leukemia K562 cells, Evid. Based Complement. Alternat. Med., 2013, 805639, 10.1155/2013/805639 · doi:10.1155/2013/805639

Cited by

See all 283

Metadata

Authors
Xiong, A., Yang, Z., Shen, Y., Zhou, J., & Shen, Q.
Venue
Cancers
Publisher
MDPI AG
Published
2014-04-16
Volume
6
Issue
2
Pages
926-957
ISSN
2072-6694 (ISSN-L)
OpenAlex
W2096551654
Cited by
283
References
198
FWCI
10.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention. https://app.cochat.ai/papers/10.3390/cancers6020926
The paper
Xiong, A., Yang, Z., Shen, Y., Zhou, J., & Shen, Q. (2014). Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention. Cancers. https://doi.org/10.3390/cancers6020926

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.